z-logo
open-access-imgOpen Access
How we treated a kidney transplant recipient who was receiving sirolimus during the SARS-CoV-2 pandemic? primum non nocere”
Author(s) -
Hamad Dheir,
Didar Şenocak,
Savaş Sipahi,
Yasemin Gündüz,
Selçuk Yaylacı,
Necattin Fırat,
Ahmed Bilal Genç,
Mehmet Köroğlu
Publication year - 2022
Publication title -
sakarya tıp dergisi
Language(s) - English
Resource type - Journals
ISSN - 2146-409X
DOI - 10.31832/smj.783277
Subject(s) - medicine , azithromycin , hydroxychloroquine , sirolimus , kidney transplantation , prednisolone , primum non nocere , everolimus , transplantation , population , surgery , covid-19 , antibiotics , disease , environmental health , infectious disease (medical specialty) , microbiology and biotechnology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here